Mass General Brigham · 3 months ago
Clinical Research Coordinator I SLEEP MED Spanish Speaking
Mass General Brigham is a not-for-profit organization dedicated to advancing patient care, research, teaching, and community service. They are seeking a Clinical Research Coordinator I to assist with a comparative effectiveness study on insomnia therapies, responsible for recruiting participants, collecting data, and ensuring adherence to study protocols. Fluency in English and Spanish is preferred for effective communication with clinical staff and study participants.
Health CareHome Health CareMedical
Responsibilities
Assist with a comparative effectiveness study testing how three therapies for insomnia compare to each other
Recruit, randomize, and collect data on study participants across the MGB system
Collect adverse event data and ensure timely follow-up by a study physician
Facilitate distribution of study interventions and monitor adherence
Work closely with study leadership and clinical program staff to operationalize and support study procedures across sites
Communicate directly with clinical staff and engage clinicians
Qualification
Required
Bachelor's Degree Science required
Some relevant research project work 0-1 year preferred
Careful attention to detail and good organizational skills
Ability to follow directions
Good interpersonal and communication skills
Computer literacy
Working knowledge of clinical research protocols
Ability to demonstrate respect and professionalism for subjects' rights and individual needs
Preferred
Fluency in English and Spanish are preferred
Benefits
Comprehensive benefits
Career advancement opportunities
Differentials
Premiums and bonuses
Recognition programs designed to celebrate your contributions and support your professional growth
Company
Mass General Brigham
Mass General Brigham specializes in providing medical treatments and health diagnostics services.
Funding
Current Stage
Late StageLeadership Team
Recent News
Research & Development World
2026-01-25
Longevity.Technology
2026-01-24
Company data provided by crunchbase